Serum HER2 supports HER2-testing in tissue at the time of primary diagnosis of breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum HER2 supports HER2-testing in tissue at the time of primary diagnosis of breast cancer

Published:2014-03 Issue: Volume:430 Page:86-91
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Di Gioia Dorit,Dresse Marie,Mayr Doris,Nagel Dorothea,Heinemann Volker,Kahlert Steffen,Stieber Petra

Publisher

Elsevier BV

Subject

Biochemistry, medical,Clinical Biochemistry,Biochemistry,General Medicine

Reference37 articles.

1. Is circulating HER-2 more than just a tumor marker?;Baselga;Clin Cancer Res,2001

2. When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer;Yamauchi;J Clin Oncol,2001

3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

4. Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancer;Carney;Clin Chem,2003

5. Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer;Carney;Clin Breast Cancer,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients;Breast Cancer: Targets and Therapy;2024-04

2. Factors influencing blood tumor marker concentrations in the absence of neoplasia;Tumor Biology;2024-03-19

3. The unique monoclonal antibodies and immunochemical assay for comprehensive determination of the cell-bound and soluble HER2 in different biological samples;Scientific Reports;2024-02-17

4. Healthy Male Individuals Possess Higher Plasma HER-2 Level than Females;CELL J;2023

5. Serum HER2 levels predict treatment efficacy and prognosis in patients with HER2-positive breast cancer undergoing neoadjuvant treatment;Gland Surgery;2021-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3